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Abstract
An acylation/deacylation cycle is necessary to maintain the steady-state subcellular distribution and biological activity of S-
acylated peripheral proteins. Despite the progress that has been made in identifying and characterizing palmitoyl-
transferases (PATs), much less is known about the thioesterases involved in protein deacylation. In this work, we
investigated the deacylation of growth-associated protein-43 (GAP-43), a dually acylated protein at cysteine residues 3 and
4. Using fluorescent fusion constructs, we measured in vivo the rate of deacylation of GAP-43 and its single acylated
mutants in Chinese hamster ovary (CHO)-K1 and human HeLa cells. Biochemical and live cell imaging experiments
demonstrated that single acylated mutants were completely deacylated with similar kinetic in both cell types. By RT-PCR we
observed that acyl-protein thioesterase 1 (APT-1), the only bona fide thioesterase shown to mediate deacylation in vivo, is
expressed in HeLa cells, but not in CHO-K1 cells. However, APT-1 overexpression neither increased the deacylation rate of
single acylated GAP-43 nor affected the steady-state subcellular distribution of dually acylated GAP-43 both in CHO-K1 and
HeLa cells, indicating that GAP-43 deacylation is not mediated by APT-1. Accordingly, we performed a bioinformatic search
to identify putative candidates with acyl-protein thioesterase activity. Among several candidates, we found that APT-2 is
expressed both in CHO-K1 and HeLa cells and its overexpression increased the deacylation rate of single acylated GAP-43
and affected the steady-state localization of diacylated GAP-43 and H-Ras. Thus, the results demonstrate that APT-2 is the
protein thioesterase involved in the acylation/deacylation cycle operating in GAP-43 subcellular distribution.
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Introduction
Fatty-acylated peripheral proteins such as members of the small
G-protein Ras family, heterotrimeric G-proteins, the neuronal
proteins PSD-95 and growth-associated protein-43 (GAP-43) [1–4]
are synthesized in the cytosol and posttranlationally modified by
different lipid moieties [5–9]. These lipid modifications govern their
membrane association and membrane subdomain segregation as
well as their trafficking, function and stability [8,10,11].
Among all posttranslational lipid modification of proteins,
including isoprenylation and myristoylation, the addition of fatty
acid to the sulfhydryl group of a cysteine to form a thioester bond
(S-acylation, often referred to as palmitoylation) is the only readily
reversible linkage having a much shorter half-life than that of the
protein [12–15]. Consequently, S-acylation can operate as a
switch regulating not only protein-membrane binding affinity and
segregation but also modulating its biological activities [16–18]. S-
acylation is catalyzed by protein acyltransferases (PATs) while
deacylation by acyl-protein thioesterases (APTs), and continuous
cycles of de- and reacylation reactions accounts for the specific
subcellular distribution of peripheral proteins as the small
GTPases H- and N-Ras [19–22].
PATs have been identified both in yeast and mammalian [18].
These proteins share a common zinc finger-like sequence,
containing a cysteine-rich domain with an aspartate-histidine-
histidine-cysteine (DHHC) motif, which mediates the PAT
activity. Although S-acylation was reported to occur in several
membrane compartments [22–24] and with apparent substrate
selectivity, a recent work from Bastiaens and coworker demon-
strated that S-acylation of semisynthetic substrates is detectable
only in the Golgi complex and, that substrate specificity is not
essential for the reacylation step [21]. Despite the progress that has
been made in identifying and characterizing PATs much less is
known about the thioesterases that deacylate proteins. So far, only
two APT has been described: palmitoyl-protein thioesterase 1
(PPT1) and acyl-protein thioesterase 1 (APT-1). PPT1 was
discovered based on its ability to deacylate H-Ras [25]. Further
research revealed that PPT1 is a lysosomal enzyme involved in
protein degradation [26] discarding the possibility to play a role in
deacylation of cytoplasmic proteins. APT-1, originally isolated
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with a widespread tissue distribution. Several proteins have been
identified as APT-1 substrates, like heterotrimeric G protein a
subunits, endothelial nitric-oxide synthase, SNAP-23 and H-Ras
as well as viral proteins [18]. In opposite to acylation, the
deacylation step seems to occurs everywhere in the cell and no
specific consensus sequence or substrate specificity has been
described for this enzymatic reaction so far [21].
In this work, we demonstrated for the first time that lysopho-
spholipase II or APT-2 is a cytosolic protein thioesterase involved
in GAP-43 deacylation. GAP-43 was early identified as a
functional growth cone marker participating in the mechanisms
of axonal outgrowth and regeneration [28–31]. Then, it was also
identified in peripheral and central glia cells and developing
muscle cells [32,33], which points to a fundamental role for GAP-
43 in cellular processes. After synthesis in the cytosol, GAP-43
binds to trans Golgi network (TGN) membranes through a process
that requires acylation of cysteine residues at positions 3 and 4
[34,35]. This posttranslational modification is necessary for GAP-
43 inclusion into exocytic and endocytic vesicular carriers.
Although several groups have described the molecular deter-
minants involved in the polarized sorting of GAP-43 in neural cells
[34,36–39], it is still unclear how this subcellular distribution is
maintained. An attractive hypothesis is that cycles of deacylation/
acylation controls GAP-43 localization and sorting [4,40,41]. In
this sense, it has been recently described that the fast kinetics and
topography of the acylation cycle allows the continuous redirection
of mislocalized proteins via the post-Golgi sorting apparatus [21].
In addition, the presence of PATs at the plasma membrane has
been also demonstrated [3,34].
Using in vivo confocal fluorescence microscopy, biochemical
analyses and bioinformatic approaches, we characterized the
deacylation kinetics of GAP-43 and identified the thioesterase
involved in this process. It was found that GAP-43 is deacylated in
vivo when expressed in Chinese hamster ovary (CHO)-K1 and
human HeLa cells through a mechanism mediated by APT-2, but
not by APT-1. Inhibition of deacylation caused GAP-43 to
accumulate in perinuclear structures while APT-2 overexpression
increased the cytoplasmic pool of GAP-43. Additionally, it was
also demonstrated that APT-2 overexpression affected the steady-
state subcellular localization of acylated H-Ras. Thus, the results
demonstrate that APT-2 is the protein thioesterase involved in the
acylation/deacylation cycle operating in GAP-43 subcellular
distribution.
Results
The Full-Length and N-terminal Domains of GAP-43 are
Deacylated In Vivo with Relatively Slow Kinetics
Previously, we characterized the acylation, membrane associa-
tion and intracellular trafficking of full-length (GAP-43
full) and the
acylation motif (MLCCMRRTKQVEK,
N13GAP-43) of GAP-43
fused to spectral variants of green fluorescent protein (GFP) [cyan
fluorescent protein (CFP) or yellow fluorescent protein (YFP)]
[34,42]. We demonstrated that both constructs are acylated at the
TGN and subsequently transported to the plasma membrane by
vesicular carriers. At the plasma membrane, these proteins are
endocytosed and directed to the recycling endosomes (RE) in an
Arf6-dependent manner. Thus, this intracellular itinerary deter-
mines the presence of GAP-43 at the TGN, plasma membrane
and RE at steady-state conditions [34,42]. In experiments carried
out to investigate GAP-43 deacylation in CHO-K1 cells, it was
observed that PATs inhibition with 100 mM 2-bromopalmitate (2-
BP) completely abolished acylation of newly synthesized GAP-43
and therefore its binding to the membranes. However, at steady-
state conditions 2-BP treatment did not modify the acylation state
and membrane binding properties of GAP-43 [34], strongly
suggesting that membrane-associated GAP-43 is not being
deacylated. However, it should be also considered that deacylated
GAP-43 could be a preferred substrate for proteasome degrada-
tion [43,44], avoiding cytosolic accumulation, and/or that 2-BP
not only inhibits PATs but also APT activity similarly to that
observed using APT-1 inhibitors [45]. To assess these alternatives,
cells expressing GAP-43 at steady-state conditions were treated
with 2-BP and cycloheximide (CHX) in the presence (+Inh) or
absence (-Inh) of proteasomal and lysosomal inhibitors during 0, 3
and 6 h (Fig. 1). As shown in Figure 1A, a significant degradation
of GAP-43 was observed along the time in the absence of
inhibitors. Contrary and supporting the previous assumption,
GAP-43 proteolysis was abolished when cells were incubated with
2-BP and CHX in the presence of protein degradation inhibitors.
Next, we investigated the in vivo deacylation kinetic of GAP-
43
full and
N13GAP-43 (Fig. 1B). Cells were treated with 2-BP
during 0, 3 and 6 h and the subcellular distribution analyzed by in
vivo confocal fluorescent microscopy. CHX and inhibitors of
protein degradation were incorporated to the culture medium 1 h
before 2-BP addition. All experiments were performed using
50 mM 2-BP to inhibit PATs without affecting APT activity
(Tomatis, Gomez and Daniotti, unpublished results) [34]. At 0, 3
and 6 h, both
N13GAP-43 and GAP-43
full localized at the plasma
membrane and perinuclear structures in control cells, as previously
reported [34]. In contrast, in 2-BP-treated cells there was a
significant amount of soluble, nonacylated GAP-43 protein at 3
and 6 h, being this more evident for GAP-43
full than
N13GAP-43.
We discarded accumulation of newly synthesized GAP-43 since
CHX was present during all the experiment. Altogether, these
results support the existence of an acylation/deacylation cycle
which operates in the membrane binding and subcellular
distribution of GAP-43. Additionally, the observed deacylation
kinetic for GAP-43
full and
N13GAP-43 was found to be comparable
to that previously described for H-Ras [19].
Single Acylated Mutant of
N13GAP-43 is Deacylated In
Vivo Faster than its Double Acylated Counterpart
Diacylated GAP-43 requires a double deacylation event for its
membrane dissociation. To investigate single deacylation events
occurring on GAP-43 and to set a more direct method for
deacylation readout, we decided to carry out our experiments
using single acylated mutants of GAP-43. Importantly, it should
also be mentioned that at steady-state conditions the monopalmi-
toylated fraction of GAP-43 represent the 60% of the total GAP-
43 protein, indicating the importance of the monoacylated specie
in GAP-43 function [46].
We generated single and double cysteine mutants at the
acylation motif of
N13GAP-43 [
N13GAP-43(C3S),
N13GAP-
43(C4S),
N13GAP-43(C3,4S)] and GAP-43
full [GAP-43
full(C3S),
GAP-43
full(C4S), GAP-43
full(C3,4S)] which were then character-
ized by in vivo confocal microscopy and biochemical analyses. As
previously observed, GAP-43
full and
N13GAP-43 localized, at
steady-state, at the RE, plasma membrane and TGN (Fig. 2A).
The point mutation at Cys
3 in
N13GAP-43 caused an accumula-
tion at the cytosol and TGN, and disrupted RE association, but
did not affect their plasma membrane association. In contrast, the
point mutation at Cys
3 in GAP-43
full disrupted the association
with the plasma membrane, drastically reduced their TGN
membrane association, and resulted in an accumulation at the
cytosol. Double mutants at Cys
3 and Cys
4 of GAP-43
full and
N13GAP-43 were not able to associate to any membranes and
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PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e15045Figure 1. GAP-43 deacylation in CHO-K1 cells. A) 24 h after transfection with plasmids for GAP-43
full-YFP or
N13GAP-43-YFP, CHO-K1 cells were
incubated with 50 mM 2-BP (2-BP) or vehicle (Control) in the presence (+Inh) or absence (-Inh) of protein degradation inhibitors for 0, 3 and 6 h. At
each time point, cells were lysed and homogenates Western blotted with an antibody to GFP. The lower panels show Western blot with antibody to
a-tubulin. B) 60 h after transfection, CHO-K1 cells expressing GAP-43
full-YFP or
N13GAP-43-YFP were treated with 50 mM 2-BP (2-BP) or vehicle
(Control) for 0, 3 and 6 h in presence of CHX and protein degradation inhibitors. At each time point the subcellular distribution was analyzed by live
cell confocal fluorescent microscopy. Scale bars: 5 mm.
doi:10.1371/journal.pone.0015045.g001
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PLoS ONE | www.plosone.org 3 November 2010 | Volume 5 | Issue 11 | e15045Figure 2. Deacylation kinetic of single acylated
N13GAP-43(C3S). A) 60 h after coexpressing GAP-43
full-YFP (GAP-43
full),
N13GAP-43-YFP
(
N13GAP-43), their S-acylation mutants (C3S, C4S or C3,4S) and
N27GalNAc-T-CFP (GalNAc-T), CHO-K1 cells were incubated with Alexa Fluor 647-Tf (Tf)
to label the RE and analyzed by live cell confocal fluorescent microscopy. The fluorescence signals from YFP, CFP and Alexa Fluor 647 were
pseudocolored green, blue and red, respectively. Each panel shows merged images from the three acquired channels. The insets in each panel show
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proteins (Fig. 2A).
The membrane association and the extent of posttranslational
modification of these constructs was further characterized by
ultracentrifugation and Triton X-114 (TX-114) partition assays
(Fig. 2B) [47]. More than 70% of GAP-43
full and
N13GAP-43 were
found to be associated with the pellet (P) fraction after
ultracentrifugation. 20% and 70% of P fraction-associated GAP-
43
full and
N13GAP-43, respectively, were found enriched in the
TX-114 detergent (D) phase, reflecting a higher hydrophobic
character for
N13GAP-43. In contrast, a drastic reduction in
membrane association (,5% in P fraction) of newly synthesized
GAP-43 was observed when cells were incubated with the PAT
inhibitor 2-BP (see nonacylated
N13GAP-43 and nonacylated
GAP-43
full in Fig. 2B). As additional control, we demonstrated that
soluble a-tubulin is mostly associated to the A (aqueous) phase of
the soluble fraction, in agreement to the biochemical properties of
this protein. 54% of GAP-43
full(C3S) and 35% of
N13GAP-43(C3S)
were found to be associated with the P fraction. Additionally, 20%
and 43% of P fraction-associated GAP-43
full(C3S) and
N13GAP-
43(C3S), respectively, were found enriched in the D phase,
reflecting a higher hydrophobic character for
N13GAP-43(C3S)
(Fig. 2B). Altogether, these results demonstrate that acylation is
necessary for GAP-43 membrane binding and that
N13GAP-
43(C3S) is the single acylation mutant having the highest
proportion of acylation and, consequently, membrane association.
Next, we evaluated the deacylation kinetics of
N13GAP-43(C3S)
in order to investigate single deacylation events occurring on GAP-
43. CHO-K1 cells transiently coexpressing
N13GAP-43(C3S) and
N27GalNAc-T (TGN marker) were treated with 50 mM 2-BP (2-
BP) or dimethylsulfoxide (DMSO, Control) and GAP-43 subcel-
lular distribution monitored at different times by live cell confocal
fluorescent microscopy (Fig. 2C). CHX and protein degradation
inhibitors were incorporated to the culture medium 1 h before and
during 2-BP treatment. In control cells, the amount of TGN-
membrane association of GAP-43(C3S) did not significantly
change over time. In opposite, TGN-associated GAP-43 signifi-
cantly decreased over time in 2-BP treated cells with a half-life of
6 min (Fig. 2C and D) clearly much faster than its wild-type
diacylated counterpart (see Fig. 1). The observed decrease of the
TGN-membrane association of GAP-43(C3S) in 2-BP conditions
was not attributed to TGN membrane redistribution, since the
TGN marker
N27GalNAc-T was not affected under these
experimental conditions, nor to an increase in TGN to plasma
membrane vesicular transport of
N13GAP-43(C3S) since all
experiments were performed at 20uC, a condition which
drastically decreases this process [34].
To support the in vivo microscopy experiments, membrane
association and extent of posttranslational modification of
N13GAP-43(C3S) were determined at the same experimental
conditions by subcellular fractionation and TX-114 partition
assay. It was found that 2-BP, when compared to control
conditions, caused a significant decrease of membrane boun-
ded-
N13GAP-43(C3S) (Fig. 2E). A similar behavior was observed
for GAP-43
full(C3S) (Fig. S1). Overall, these biochemical results
are in close agreement with those obtained by live cell confocal
microscopy analysis. To discard that the observed GAP-43
deacylation process could be a cell type-specific phenomenon,
then, we extended our analysis using human HeLa cells and found
that
N13GAP-43(C3S) is deacylated with a similar kinetics both in
HeLa and CHO-K1 cells (Fig. 2F), precluding the possibility that
GAP-43 deacylation is a cell type specific process.
These results demonstrate that
N13GAP-43(C3S) is deacylated in
vivo and that GAP-43 deacylation occurs at the TGN, besides the
plasma membrane, revealing the importance of an acylation/
deacylation cycle operating in GAP-43 subcellular distribution
[17,19,22,48,49].
GAP-43 Deacylation in CHO-K1 Cells is APT-1
Independent
Up to now, results indicate that
N13GAP-43(C3S) is deacylated
with similar kinetic when it is expressed in CHO-K1 and HeLa
cells. APT-1 is the unique described cytosolic protein thioesterase
able to catalyze the deacylation of several substrates including H-
Ras and G alpha subunit proteins [13,18,50]. However, there is no
information about the role of this enzyme on GAP-43 deacylation.
To investigate whether APT-1 deacylates GAP-43, we first
analyzed mRNA expression of APT-1 both in CHO-K1 and
HeLa cells by reverse transcriptase-polimerase reaction chain (RT-
PCR). The results showed that a PCR product of the expected size
was obtained using mRNAs from HeLa cells as template (Fig. 3A).
The same result was also obtained using mRNA from African
green monkey kidney fibroblast cells (COS-7 line) (Fig. S2). In
opposite, no amplification of any product was observed using
mRNA purified from CHO-K1 cells. Primer specificity was
validated by APT-1 cDNA amplification using genomic DNA
from CHO-K1 cells and mRNA purified from hamster brain, liver
and ovary tissues (Fig. 3A and B). The identity of all PCR products
details of the boxed area at a higher magnification with the corresponding pseudocoloured signal from each channel. Scale bars: 5 mm. B) CHO-K1
cells transiently expressing GAP-43
full-YFP (GAP-43
full), GAP-43
full(C3S)-YFP [GAP-43
full(C3S)],
N13GAP-43-YFP (
N13GAP-43) or
N13GAP-43(C3S)-YFP
[
N13GAP-43(C3S)] were lysed, ultracentrifuged and the S (soluble) and P (pellet) fraction isolated. Buffer containing 1% v/v Triton X-114 was added to
samples and phase separation was induced at 37uC. Proteins from the A (aqueous) and D (detergent) phases were Western blotted with an antibody
to GFP. To obtain nonacylated GAP-43
full and
N13GAP-43, CHO-K1 cells were transfected with the corresponding plasmids in presence of CHX. 30 min
before CHX withdrawal, cells were incubated with 50 mM 2-BP until 3 h after CHX withdrawal. S and P fractions were isolated and analyzed by
Western blot as explained above. The lower panels show the Western blot using antibody to a-tubulin. C) 60 h after transient transfection, CHO-K1
cells coexpressing
N13GAP-43(C3S) and
N27GalNAc-T were treated with 50 mM 2-BP (2-BP, lower panels) or vehicle (Ctrl, upper panels) in presence of
CHX and protein degradation inhibitors during 30 min before imaging and during all the experiment. GAP-43 subcellular distribution was analyzed
by live cell confocal microscopy. Panels show YFP (pseudocolored gray) and CFP (pseudocolored gray), and merge images from YFP (pseudocolored
green) and CFP (pseudocolored red) signals at 0, 5, 10 and 15 minutes after 2-BP or vehicle addition. Scale bars: 5 mm. D) Quantification of images
showed in 2C (see Materials and Methods). E) Upper, 24 h after transfection, CHO-K1 cells transiently expressing
N13GAP-43(C3S)-YFP [
N13GAP-
43(C3S)] were lysed, ultracentrifuged and the S and P fraction were recovered. Buffer containing 1% v/v Triton X-114 was added to samples and
phase separation was induced at 37uC. Proteins from the A and D phases were Western blotted with an antibody to GFP and a-tubulin. Lower,
quantification (as described in Materials and Methods) of Western blot showed in upper panels. F) Left, 60 h after transient transfection, CHO-K1 and
HeLa cells coexpressing
N13GAP-43(C3S)-YFP and
N27GalNAc-T-CFP were treated with 50 mM 2-BP (2-BP, lower panels) or vehicle (Control, upper
panels) in presence of protein degradation inhibitors during 30 min. GAP-43 subcellular distribution was analyzed by live cell confocal microscopy.
Each panel shows image from YPF (pseudocoloured gray) channel at 0, 5, 10 and 15 min from the beginning of the experiment. The insets in each
panel show (from left to right): YFP fluorescence (pseudocolored green), CFP fluorescence (pseudocolored red) fluorescence and the merge of both
fluorescence signals. Scale bars: 5 mm. Right, quantification of images showed in left panels (see Materials and Methods).
doi:10.1371/journal.pone.0015045.g002
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PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e15045Figure 3. GAP-43 deacylation is not mediated by APT-1. A) PCR analysis of APT-1 expression using specific primers and the following
templates: the reaction mixture [ctrl (-)]; a plasmid containing the cDNA coding APT-1 [ctrl (+)]; genomic DNA from CHO-K1 cells (gDNA CHO-K1); first-
strand cDNA obtained from RT of CHO-K1 cells purified mRNA (RT-PCR CHO-K1 cells); genomic DNA from HeLa cells (gDNA HeLa) and first-strand
cDNA obtained from RT of HeLa cells purified mRNA (RT-PCR HeLa cells). Genomic DNA and mRNA were extracted from CHO-K1 and HeLa cells. B)
PCR analysis of APT-1 expression using as template: first-strand cDNA obtained from RT of HeLa cells purified mRNA [ctrl (+)]; the reaction mixture
[ctrl (-)] and first-strand cDNA obtained from mRNA of hamster brain (RT-PCR Brain), liver (RT-PCR Liver) and ovary (RT-PCR Ovary). C) 60 h after
transient transfection, CHO-K1 cells expressing
N13GAP-43(C3S) alone (Control, upper panels) or coexpressing
N13GAP-43(C3S) and APT-1(APT-1, lower
panels) were treated with 50 mM 2-BP. CHX and protein degradation inhibitors were added 30 min before imaging and maintained in the culture
media until the end of each experiment. GAP-43 subcellular distribution was monitored by live cell confocal microscopy. Each panel shows image
from YPF fluorescence (pseudocoloured gray) at 0, 5, 10 and 15 min from 2-BP addition. The insets in each panel show (left to right): YFP fluorescence
(pseudocoloured green), CFP fluorescence (pseudocoloured red) and the merge of both fluorescence signals. D) Quantification [
N13GAP-43(C3S)
associated to TGN membranes] of images showed in panels C (see Materials and Methods). E) 60 h after transient transfection, CHO-K1 cells
expressing H-RasG12V (upper panels) or coexpressing H-RasG12V and APT-1 (lower panels) were treated with 50 mM 2-BP (2-BP) or vehicle (Ctrl) in
presence of CHX and protein degradation inhibitors for 0, 3 and 6 h and the subcellular distribution analyzed by live cell confocal microscopy. Each
panel shows image from YFP fluorescence (pseudocoloured gray). The insets show the cells expressing APT-1 (cherry fluorescence). F) S fraction from
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amino acid sequence between human and hamster APT-1 (results
not shown).
Thus, results demonstrated that APT-1 is not expressed in
CHO-K1 cells. To discard the possibility that very low
endogenous expression level of APT-1 could be deacylating
GAP-43, we evaluated the deacylation kinetics of
N13GAP-43(C3S)
in CHO-K1 cells overexpressing or not human APT-1 fused to
mCherry fluorescent protein (hereafter APT-1, Fig. 3C and D).
The deacylation kinetics of GAP-43 was evaluated by analyzing
the rate of
N13GAP-43(C3S)-TGN-membrane association decay-
ment after 2-BP treatment. Results clearly indicated that APT-1
overexpression in CHO-K1 cells did not significantly modify the
decay rate of
N13GAP-43(C3S) at the TGN compared to cells only
expressing
N13GAP-43(C3S). Additionally, we also found that
APT-1 overexpression did not significantly modify membrane
association and deacylation kinetic of diacylated
N13GAP-43 and
GAP-43
full (Fig. S3). To further analyze the effect of APT-1
activity on
N13GAP-43(C3S), we performed an in vitro deacylation
assay (Fig. 3F). For these experiments, cytosolic fractions were
prepared from CHO-K1 cells expressing
N13GAP-43(C3S) or a
fusion protein containing the C-terminal hypervariable region of
K-Ras fused to YFP (K-Ras
C14), and particulate fractions from
nontransfected cells [47]. Soluble fractions from transfected cells
were incubated with membranes from nontransfected cells for 1 h
at 4uC and then ultracentrifuged to separate soluble and
particulate fractions. The isolated particulate fraction containing
monoacylated GAP-43 or prenylated K-Ras was incubated for 1 h
at 30uC in the presence (+APT-1) or the absence (-APT-1) of
recombinant APT-1 [13]. Next, soluble and particulate fractions
were separated by ultracentrifugation and presence of
N13GAP-
43(C3S) in the fractions evaluated by Western blot. Results
indicated that the incubation with recombinant APT-1 did not
significantly increase the amount of
N13GAP-43(C3S) recovered in
the soluble fraction. As expected, the amount of nonpalmitoylated
K-Ras isoform present in the soluble fraction was independent of
the presence of APT-1 (result not shown). Thus, these results
strongly support the concept that APT-1 does not catalyze both in
vitro and in vivo
N13GAP-43(C3S) deacylation.
As additional control of APT-1 activity, we evaluated the effect
of ectopically expressed APT-1 on H-RasG12V deacylation and
its consequences on subcellular distribution. APT-1 has been
identified as one of the thioesterases in the acylation cycle of H-
Ras both in vivo [21,50] and in vitro [13]. In addition, it was
demonstrated that oncogenic H-RasG12V is deacylated faster
than its wild-type counterpart [15]. As shown in Figure 3E, H-
RasG12V localizes at the plasma membrane and perinuclear
structures previously identified as RE [42]. Treatment of CHO-
K1 cells with 2-BP for 3 h led to a redistribution of H-RasG12V to
perinuclear structures, which resembles the Golgi complex and the
endoplasmic reticulum in agreement with subcellular distribution
observed for nonpalmitoylated H-Ras [19,22,51]. A total redistri-
bution of H-RasG12V to endomembranes was observed at 6 h
after 2-BP treatment. By the contrary, when CHO-K1 cells
coexpressing APT-1 and H-RasG12V were incubated with 2-BP,
a faster and marked H-Ras subcellular redistribution was evident
at 3 h. This result demonstrates that APT-1 is able to participate
in the acylation cycle of H-RasG12V, which is consistent with
already published data [50]. Altogether, these results indicate that
APT-1 is not the enzyme responsible for GAP-43 deacylation in
CHO-K1 cells. As CHO-K1 cells do not naturally express APT-1,
the results strongly suggest the existence of other uncharacterized
acyl-protein thioesterase.
Bioinformatic Search and Expression Profiles Define Acyl-
Protein Thioesterase 2 (APT-2) as the Enzyme
Responsible for GAP-43 Deacylation in CHO-K1 Cells
To identify the enzyme/s responsible for GAP-43 deacylation in
CHO-K1 cells, we performed a bioinformatic search based on
shared properties of the only two proteins described with APT
activity, APT-1 and PPT-1. First, we performed a Blast search for
nonredundant human protein sequences which align to PPT-1
and/or APT-1 protein sequences. In addition, we searched for
members of APT-1 and/or PPT-1 families in Pfam databases
(http://pfam.sanger.ac.uk/) [#PF02230 (APT-1) and #PF02089
(PPT-1)]. After careful classification and removal of redundant
sequences, the in silico analysis allowed us to identify 21 potential
acyl thioesterase transcripts, which are codified for 5 different
genes (Table S1). To simplify the experimental screening, we first
determined transcript expression in CHO-K1 and HeLa cells by
RT-PCR using specific primers for each gene (without discrim-
ination of mRNA isoforms, Fig. 4A). In parallel, we also
determined transcription profiles in the neuroblastoma cell line
SH-SY5Y (undifferentiated and retinoic acid-differentiated) and
SK-Mel28 cells (Fig. S4).
We found that transcripts coded by gene ID 11313 were
expressed in much higher amount in HeLa, SH-SY5Y and SK-
Mel-28 cells than in CHO-K1 cells. Interestingly, we observed
that the expression level of transcripts coded for this gene
increased in retinoic acid-treated SYSH-5Y cells when compared
to control conditions. In addition, transcripts coded by gene ID
127018 and gene ID 339168 were only found in neuronal (SH-
SY5Y) and epithelial (CHO-K1) cells, respectively. Finally,
transcripts coded by gene ID 10434 were found in all analyzed
cell lines, except CHO-K1 cells. Thus, the transcription profile of
genes ID 127018, 339168 and 10434 did not explain for the
presence of acyl-protein thioesterase activity both in CHO-K1 and
HeLa cells. Consequently, results strongly suggest that gene ID
11313 potentially code for an acyl-protein thioesterase for GAP-
43.
To identify transcripts derived from gene ID 11313 potentially
coding for GAP-43 acyl-protein thioesterases, we evaluated their
expression both in CHO-K1 and HeLa cells by RT-PCR using
specific primers for each transcript (Fig. 4B). Results show that
APT-2 is the only isoform expressed both in CHO-K1 and HeLa
cells, and suggest that it could be a potential candidate involved in
GAP-43 deacylation. Sequence analysis revealed a high degree of
conservation between APT-2 from CHO-K1 and HeLa cells
(aminoacid identity: 99%; nucleotide sequence 93%) (Table S2).
APT-2 Overexpression Increases the Deacylation Rate of
GAP-43
Bioinformatic search and mRNA expression experiments
suggested that APT-2 is a potential acyl-protein thioesterase for
GAP-43. To test this hypothesis, we evaluated the effect of APT-2,
fused to mCherry fluorescent protein (hereafter APT-2), overex-
pression on
N13GAP-43(C3S) deacylation in CHO-K1 cells by live
CHO-K1 cells transiently expressing
N13GAP-43(C3S) was incubated with P fraction from nontransfected CHO-K1 cells during 1 h at 4uC. Then, the P
fraction was isolated by ultracentrifugation and incubated in the presence (APT-1) or the absence (Control) of recombinant APT-1. Then, S and P
fractions were separated by ultracentrifugation and proteins from each fraction Western blotted using an antibody to GFP. Scale bars: 5 mm.
doi:10.1371/journal.pone.0015045.g003
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measured
N13GAP-43(C3S) deacylation in cells which did not
overexpress APT-2 (Fig. 5A). As previously determined, the half-
time of the decay of TGN-membrane associated GAP-43 at the
TGN after 2-BP addition in cells which only expresses
N13GAP-
43(C3S) was 6 min (see Fig. 2). In a clear contrast, we observed
that in cells expressing APT-2, the half-time of
N13GAP-43(C3S)
deacylation was reduced to 3 min (Fig. 5B), demonstrating that
APT-2 catalyze in vivo deacylation of
N13GAP-43(C3S).
To further extent our research, we investigated the effect of
APT-2 overexpression on GAP-43
full and
N13GAP-43 deacylation.
For this, we analyzed the effect of 2-BP treatment on GAP-43
subcellular distribution in cells expressing GAP-43 alone or
coexpresing GAP-43 and APT-2 (Fig. 5C and D). We observed
that in the absence of APT-2, GAP-43 (
N13GAP-43 and GAP-
43
full) deacylation was partially evident after 3 h of 2-BP treatment
(compare Control with 2-BP condition), maintaining a significant
amount of plasma membrane-associated GAP-43. In contrast,
after 6 h of 2-BP treatment, we observed nuclear accumulation of
soluble GAP-43 and a clear reduction of GAP-43 at the plasma
membrane, which indicate that it is highly deacylated under this
condition. On the other hand, the overexpression of APT-2 caused
a significant reduction in the plasma membrane content of GAP-
43
full at 3 h of 2-BP treatment (Fig. 5C). In addition, it was also
observed at this time an appreciable accumulation of soluble GAP-
43 in the nuclei when compared to cells expressing only GAP-43.
A similar result was also observed when we analyzed the effect of
APT-2 overexpression on
N13GAP-43 deacylation (Fig. 5D).
Altogether, these results indicate that APT-2 is a novel acyl-
protein thioesterase which is able to deacylate GAP-43.
Effect of APT-2 Overexpression on the Deacylation Rate
of H-RasG12V
After identifying GAP-43 as a substrate of APT-2, we
investigated the effect of APT-2 expression on H-RasG12V
deacylation and subcellular distribution (Fig. 6). Similar to results
obtained in CHO-K1 cells coexpressing APT-1 and H-RasG12V
(Fig. 3E), APT-2 expression caused a total H-RasG12V redistri-
Figure 4. Analysis of acyl-protein thioesterase expression in CHO-K1 and HeLa cells. A) PCR analysis of gene expression in CHO-K1 (upper
panels) and HeLa cells (lower panels). For each indicated gene (see gene number at the top), PCRs were performed using specific primers and the
following templates: reaction mixture [Ctrl (-)]; genomic DNA (gDNA) and first-strand cDNA obtained from RT of mRNA (RT-PCR). B) PCR analysis of
isoform expression coded by gene # 11313. For each isoform indicated at the top, PCRs were performed using specific primers and the following
templates: first-strand cDNA obtained from RT of HeLa cells purified mRNA (HeLa RT-PCR); CHO-K1 genomic DNA (CHO-K1 gDNA) and first-strand
cDNA obtained from RT of CHO-K1 cells purified mRNA (CHO-K1 RT-PCR).
doi:10.1371/journal.pone.0015045.g004
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Thus, results demonstrate that H-RasG12V deacylation rate in
cells coexpressing APT-2 is much higher than the observed in cells
expressing H-RasG12V alone (see Fig. 3E) and suggest that, like
APT-1, APT-2 is also able to deacylate H-Ras in vivo.
Discussion
The major aim of this study was to gain insight into the mechanisms
participating in GAP-43 deacylation. Using confocal and video
fluorescence microscopy in living cells, in association with biochemical
approaches, we demonstrated in HeLa and CHO-K1 cells that both
N13GAP-43 and GAP-43
full are completely deacylated in vivo in a scale
time of hours. In addition, single acylated mutants of GAP-43 were
found to be deacylated faster than their double acylated counterparts.
GAP-43 deacylation was not catalyzed by APT-1, the only bona fide
cytosolic protein thioesterase described so far. By bioinformatic search,
molecular biology techniques and later cell imaging analysis, we
identified and characterized the phospholipase like protein APT-2 as
the enzyme involved in GAP-43 deacylation.
It had beenearly demonstratedthat GAP-43 is deacylated in vivo
[21,22,40,41] and that at steady-state conditions there are a variety
Figure 5. APT-2 overexpression increases the deacylation rate of GAP-43. A) 60 h after transient transfection, CHO-K1 cells expressing
N13GAP-43(C3S) (Control, upper panels) or coexpressing
N13GAP-43(C3S) and APT-2 (APT-2, lower panels) were treated with 50 mM 2-BP. CHX and
protein degradation inhibitors were added 30 min before imaging and maintained in the culture media until the end of each experiment. GAP-43
subcellular distribution was analyzed by live cell confocal microscopy. Each panel shows image from YPF fluorescence (pseudocolored gray) at 0, 5,
10 and 15 min from 2-BP addition. The insets in each panel from left to right show: YFP fluorescence (pseudocolored green), CFP fluorescence
(pseudocolored red) and the merge of both fluorescence signals. B) Quantification [
N13GAP-43(C3S) associated to TGN membranes] of images
showed in panels a (see Materials and Methods). C) 60 h after transient transfection, CHO-K1 cells expressing GAP-43
full (upper panels) or
coexpressing GAP-43
full and APT-2 (lower panels) were treated with 50 mM 2-BP (2-BP) or vehicle (Ctrl) in the presence of CHX and protein
degradation inhibitors for 0, 3 and 6 h and the GAP-43 subcellular distribution was analyzed by live cell confocal microscopy. Each panel shows image
from YFP fluorescence (pseudocolored gray). The insets show cells expressing APT-2 (cherry fluorescence, pseudocolored gray). D) 60 h after
transient transfection, CHO-K1 cells expressing
N13GAP-43 (upper panels) or coexpressing
N13GAP-43 and APT-2 (lower panels) were treated with
50 mM 2-BP (2-BP) or vehicle (Ctrl) in the presence of CHX and protein degradation inhibitors for 0, 3 and 6 h and the subcellular distribution was
analyzed by live cell confocal microscopy. Each panel shows image from YFP fluorescence (pseudocolored gray). The insets indicate cells expressing
APT-2 (cherry fluorescence, pseudocolored gray). Scale bars: 5 mm.
doi:10.1371/journal.pone.0015045.g005
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double acylated forms [46]. Although in vitro experiments shown
that an acylated peptide substrate derived from GAP-43
(MLCCMRR) was efficiently deacylated by PPT-1 at neutral pH
[52], the lysosomal localization of this enzyme preclude the
possibility that it is involved in cytosolic GAP-43 deacylation
[21,53-55]. In opposite,APT-1,originallyisolated from ratliver asa
lysophospholipase [27], appears to be involved in the regulation of
the reversible S-acylation of cytoplasmic proteins in vivo, like
heterotrimeric G protein a subunits, endothelial nitric-oxide
synthase, SNAP-23 and H-Ras as well as viral proteins [18].
However, evidence also indicates that APT-1 does not deacylate
proteins without any discrimination. For instance, caveolin is not
deacylated by APT-1 [56] and not all substrates are deacylated with
the same efficiency [57]. Regarding GAP-43 deacylation, there is
not any direct evidence suggesting the participation of APT-1.
Taken into consideration these antecedents, we attempted to
evaluate the role of APT-1 in GAP-43 deacylation. First of all, we
demonstrated that wild-type or single acylation mutants of GAP-
43 are deacylated in CHO-K1 cells. This result is compatible with
those recently published [21] and in agreement with previous
reports [40,41]. Interestingly, we demonstrated that APT-1 is not
expressed in CHO-K1 cells and that APT-1 overexpression did
not significantly increase the deacylation rate of monoacylated or
wild-type GAP-43 but did enhance the deacylation rate of H-
RasG12V protein. Paradoxically, APT-1 overexpression caused
an accumulation of GAP-43
full at the Golgi complex, a
phenomena which could be compatible with an increase in
acylation activity probably mediated by APT-1 since under the
experimental conditions used in Figure S3 endogenous PAT
activity, but not APT-1, was inhibited at 50 mM 2-BP (Tomatis,
Gomez and Daniotti, unpublished results). In this sense, it was
previously described that APT-1 may not only function as a
thioesterase but also as an acyltransferase. Particularly, it was
demonstrated an APT-1-mediated S-palmitoylation of H- and N-
Ras [45]. Additionally, the no accumulation of
N13GAP-43 at the
Golgi complex in APT-1 expressing CHO-K1 cells could be
reflecting substrate selectivity or structural preference of APT-1 to
exert a proper acylation/reverse hydrolysis.
To identify the enzyme/s responsible for GAP-43 deacylation,
we performed a bioinformatic search based on shared properties of
the only two proteins described with APT activity, APT-1 and
PPT-1. Results show that APT-2 is the only isoform expressed
both in CHO-K1 and HeLa cells, and suggested that it could be a
potential candidate involved in GAP-43 deacylation. Subsequent
experiments using live cell imaging analysis confirmed the
bioinformatic results and demonstrated for the first time that
APT-2 behave as acyl-protein thioesterase which is able to
deacylate either GAP-43
full or
N13GAP-43.
Mouse APT-2, which shares 64% identity with rat and mouse
APT-1, was found to be ubiquitously expressed in mouse tissues
and able to hydrolyze several lipid substrates with varied efficiency
[58,59]. Sequence analysis using the PSORTII program (http://
psort.hgc.jp/form2.html) indicates that APT-2 is likely a soluble
protein. By fusing the cDNA encoding this protein to fluorescent
proteins, we found that APT-2 is mostly cytosolic and there is not
any apparent membrane association. This fact strongly suggests
that APT-2 can deacylate GAP-43 by transient binding to the
membrane-cytosol interface probably in a widely distributed
process. In particular, we observed that deacylation of mono-
acylated
N13GAP-43 occurs as early in the acylation cycle as at the
Golgi complex. In agreement with this result, it was recently
demonstrated that palmitate removal of H-Ras mutants (mono
and double-palmitoylated) takes place at the Golgi complex [21].
Although some patterns of S-acylation exist, there is no specific
consensus sequence for S-acylation. Similarly, it has not been
defined so far a consensus for the sequences surrounding the
thioacyl group which could be recognized by APT-1. In vitro,
APT-1 can depalmitoylate structurally different proteins (soluble
or integral membrane proteins), having different subcellular
distributions and S-acylated either at the N- (i.e. endothelial
nitric-oxide synthase and Gia1) or at the C-terminus (i.e. H-Ras)
[18]. We observed that, like APT-1, APT-2 has not an easily
detected consensus sequence for deacylation. We demonstrated
that APT-2 can deacylate two unrelated proteins like H-Ras,
which is modified at its C-terminus by both acylation and
prenylation and GAP-43, which is acylated on N-terminal
cysteines 3 and 4. Moreover, we observed variable substrate
preference for APT-2 when compared deacylation of GAP-43
full
and the acylation motif of GAP-43 fused to YFP.
Concerning APT-2 deacylation of H-Ras, it was early
speculated it could be occurring in yeast cells where the APT-1
Figure 6. Effect of APT-2 overexpression on the deacylation rate of H-RasG12V. 60 h after transient transfection, CHO-K1 cells
coexpressing H-RasG12V and APT-2 were treated with 50 mM 2-BP (2-BP) or vehicle (Ctrl) in the presence of CHX and protein degradation inhibitors
for 0, 3 and 6 h and H-RasG12V subcellular distribution analyzed by live cell confocal microscopy. Each panel shows image from YFP fluorescence
(pseudocolored gray). The insets show cells expressing APT-1 (cherry fluorescence). Scale bar: 5 mm.
doi:10.1371/journal.pone.0015045.g006
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activity against acylated H-Ras was similar to that of wild-type
yeast [57]. In this sense, our results agree with this hypothesis and
support the fact that both APT-1 and APT-2 mediate H-Ras
deacylation. However, bioinformatic search do not indicate that
APT-2 homologue exists in yeast, suggesting that in this organism
Ras deacylation might be catalyzed by another still unidentified
thioesterase protein [18].
Previously, it was demonstrated that proteasome inhibitors
increase the cellular GAP-43 level, leading to the accumulation of
polyubiquitinated forms of this protein in transfected cells.
Moreover, the ubiquitin-proteasome pathway was described to
be important in the turnover of this protein in neuron cells [43,44].
In this work, we show that 2-BP treatment caused a significative
reduction in the amount of transiently expressed GAP-43.
Interestingly, we demonstrated that the reduction in the protein
level was abrogated when cells were also treated with proteasome
inhibitors (chloroquine, MG132 and lactacystin) which strongly
suggest that GAP-43 deacylation is an early and necessary step for
its later ubiquitination and degradation by the proteasome. In
addition, it also suggests that acyl-protein thioesterase levels not
only regulate palmitate turnover but also global protein turnover
of GAP-43.
Materials and Methods
Plasmids
The expression vectors pECFP-C1 (where ECFP, enhanced
CFP), pEYFP-N1 (where EYFP, enhanced YFP), pECFP-C1,
pEYFP-C1, pEGFP-F, pmCherry-C1 and the plasmid encoding
GFP-H-Ras
C20 were from Clontech (CA, USA). Expression
plasmids for
N13GAP-43-(YFP), GAP-43
full-(YFP) and its acylation
mutants, (YFP)-K-Ras
C14, YFP-H-Ras
full,
N27GalNAc-T-CFP and
N52Gal-T2-CFP have been previously described [34,42,47,60].
The expression plasmid encoding YFP-H-Ras
G12V was performed
by directed mutagenesis of YFP-H-Ras
full using PCR. Both
Cherry-APT-1 and Cherry-APT-2 constructs were obtained by
RT-PCR using purified mRNA from HeLa and CHO-K1 cells,
respectively, and the amplified products were cloned into
pmCherry-C1 using EcoRI and SalI restriction sites.
Cell Culture and DNA Transfections
CHO-K1, HeLa, SK-Mel 28 and SHSY-5Y cells (ATCC,
Manassas, VA, USA) were maintained at 37uC, 5% CO2 in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (FBS) and antibiotics (ATB, 100 mg/ml
penicillin and 100 mg/ml streptomycin). To induce SH-SY5Y
differentiation, cells were incubated with 30 mM retinoic acid for 6
days. Cells grown on Petri dishes were used for both live cell
imaging and Western blot experiments. Cells were transfected with
0.6–1.2 mg/35 mm dish of the indicated plasmid using cationic
liposomes (Lipofectamine, Invitrogen, CA, USA) or polyethylei-
mine (PEI, Sigma-Aldrich, St Louis, MO, USA). At 24 h after cell
transfection, cells were processed for Western blot experiments or
plated onto coverslips, incubated for 24 h, and used in live cell
imaging.
2-BP Treatment
The stock solution of 2-BP (0.42 M, Fluka) was prepared in
DMSO. CHO-K1 and HeLa cells expressing recombinant
proteins were incubated with 50 mM 2-BP or vehicle (DMSO)
for control cells for the indicated times. To analyze the effect of 2-
BP on the steady state subcellular distribution of fluorescent
proteins, CHO-K1 and HeLa cells were treated with 60 or
150 mg/ml CHX (Sigma-Aldrich), respectively, and inhibitors of
protein degradation (60 mM cloroquine and 7.5 mM MG132).
These inhibitors were added to the culture medium 24 h after cell
transfection and 1 h before 2-BP treatment (Western blot
experiments) or 36 h after platting transfected cells onto coverslips
(live cell imaging). In live cell imaging experiments, coverslips were
mounted on the microscope stage and 2-BP was added during
time series acquisition.
To analyze the effect of acylation inhibition on membrane
binding properties of GAP-43, 50 mg/ml CHX was incorporated
to the culture medium during the transfection. Then, 5 h after
transfection, 10% FBS was added to the medium and 2h later
50 mM 2-BP was also incorporated. After 1 h of 2-BP treatment,
CHX was removed by three washes with DMEM containing FBS,
antibiotics and 2-BP. Finally, after 4 h of CHX withdrawal, cells
were scrapped and used for biochemical experiments.
Electrophoresis and Western Blotting
Electrophoresis, transfer onto nitrocellulose membranes and
protein immunodetection were performed as described by [47].
Anti-GFP polyclonal antibody (Roche Diagnostics, IN, USA) was
used at a dilution of 1:700. Antibodies were detected using near-
infrared fluorescence (Li-COR Biotechnology, Lincoln, NE, USA)
with secondary antibody coupled to IRDye800CW (Li-COR
Biotechnology). The relative contribution of individual bands was
calculated using the computer software ImageJ (National Institute
for Health, Bethesda, MA, USA) on raw nonsaturated digital
images and the
N13GAP-43 Kp value determined as follow:
Kp~
S
P
~
ASzDS 
APzDP ðÞ
Where S and P refer to the amount of GAP-43 present in S
[Aqueous (A) plus Detergent (D) fractions] and P (A plus D
fraction), respectively, after background subtraction. Values of Kp
were normalized to those observed in control conditions.
Subcellular Fractionation and TX-114 Partition Assay
Cells grown onto 60 mm dishes were washed with cold PBS
(140 mM NaCl, 8.4 mM Na2HPO4, 1.6 mM NaH2PO4, pH 7.5);
and harvested by scrapping in PBS containing a protease inhibitor
mixture (PIM) containing 5 mg/ml aprotinin, 0.5 mg/ml leupeptin,
and 0.7 mg/mL pepstatin (PBS-PIM). Extracts were centrifuged at
4uC for 5 min at 13000 g and resuspended in 400 mlo f5m M
Tris-HCl (pH 7.0) (buffer T) in the presence of protease inhibitors
(T-PIM). Pellets were dispersed by repeated pipetting and
vortexing. After 30 min of incubation in T-PIM, pellets were
passed 60 times through a 25-gauge needle. Nuclear fractions and
unbroken cells were removed by twice centrifugation at 4uC for
5 min at 600 g. Supernatants were then ultracentrifuged at 4uC for
1 h at 400000 g using a TLA 100.3 rotor (Beckman Coulter, Inc.,
CA, USA). The supernatant (S1 fraction) was removed, and the
pellet (P1 fraction) was resuspended in 400 ml of T-PIM. Both
fractions were further ultracentrifuged at 400000 g and the
supernatant of S1 fraction was removed (S fraction) and the pellet
of P1 fraction was resuspended in 400 ml of T-PIM (P fraction).
100 ml of 5% (v/v) TX-114 in T-PIM was added to S and P
fractions and incubated at 4uC during 1 h. Then, samples were
incubated at 37uC for 3 min and centrifuged at 13000 g. The
aqueous upper phase (A) and the detergent-enriched lower phase
(D) were separated and extracted again with detergent and
aqueous solutions, respectively. The resulting samples were
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were precipitated with chloroform/methanol (1:4 v/v) for Western
blot analyses.
Expression and Purification of Recombinant APT-1
The APT-1 cDNA containing a Hisx6 tag was obtained by RT-
PCR using specific primers and RNA from HeLa cells. The
amplified fragment was cloned into BamHI/EcoRI sites of the
bacterial expression vector pRSET-A (Invitrogen, USA). Trans-
formed Escherichia coli cells were growth at 37uC in LB medium
containing 75 mg/ml ampicilin to an optical density of 0.6. Then,
a soluble fraction was generated by sonication, lyzosyme treatment
(200 mg/ml, 30 min at room temperature), and centrifugation at
10000 g for 15 min at 4uC. Hisx6-APT-1 was then purified from
the soluble lysate using a Ni
2+-NTA column (GE Healthcare,
Fairfield, VT, USA) according to manufacturer’s instructions.
Assessment of
N13GAP-43(C3S) In Vitro Depalmitoylation
by Purified APT-1
To examine the ability of purified recombinant APT-1 to
depalmitoylate
N13GAP-43(C3S), S and P fractions were obtained
from
N13GAP-43(C3S) transfected and nontransfected CHO-K1
cells, respectively, by ultracentrifugation as described above. S0
fractions were cleared and P0 fractions were washed by
ultracentrifugation. Membrane binding of soluble
N13GAP-
43(C3S) protein was done by incubation of S0 fractions obtained
from transfected cells with P0 fractions obtained from untrans-
fected cells for 1 h at 4uC. The resultant mixture was then
ultracentrifuged for 1 h at 4uC and the pellet fraction (P1) was
resuspended in 400 ml APT-1 reaction buffer (50 mM Hepes,
2 mM CaCl2, 0.1 mM EDTA, pH 8.0) containing protease
inhibitors (PIM plus 1 mM PMSF) and ultracentrifuged again.
The resultant P2 fraction was resuspended in 250 ml APT-1
reaction buffer containing PIM/PMSF and subjected to acyl-
protein thioesterase treatment by incubation with recombinant
APT-1 as previously described [13,14,25] with some modifica-
tions. Reactions were performed by mixing 100 mlo fP 2 fraction
with 2 mg recombinant APT-1 (0.18 mg/ml; APT-1 reactions) or
11.1 ml of APT-1 carrier buffer (1M Tris-HCl:glycerol, 1:1;
Control reactions) and incubated at 30uC for 1 h. Then, 300 ml
of APT-1 reaction buffer was added to samples and subjected to
ultracentrifugation. P fractions were then resuspended in the same
reaction buffer. Proteins from resulting fractions were precipitated
with 10% trichloroacetic acid as described previously [61] and
analyzed by Western blot using an antibody to GFP. As a control,
we also evaluated under the same experimental conditions the
effect of recombinant APT-1 on membrane binding properties of
YFP-K-Ras
C14 [47].
Confocal Microscopy
Confocal images were collected using an Olympus FluoView
FV1000 confocal microscope (Olympus Latin America, Miami,
FL) equipped with a multi-line Argon laser (458, 488 and 514 nm),
two Helium Neon lasers (543 nm and 633 nm, respectively). CFP
was detected by using laser excitation at 458 nm; a 458/514 nm
excitation dichroic mirror and a 470–500 nm bandpass emission
filter. YFP was acquired by using laser excitation at 514 nm, a
458/514 nm excitation dichroic mirror and a 530–570 nm
bandpass emission filter. Cherry protein was acquired with a laser
excitation at 543 nm, a 488/543/633 nm excitation dichroic
mirror, and a 560 nm long pass emission filter. For CFP/YFP or
CFP/YFP/Cherry acquisition, images were sequentially acquired
in line mode. This minimizes the bleed-through between channels,
mainly due to overlapping emission spectra of these fluoro-
chromes.
i) Live Cell Imaging for Subcellular Distribution Analyses.
For subcellular distribution analyses and colocalization of GAP-43
proteins with organelle markers, live cell experiments were performed
at 3562uC (Tritech DigiTherm temperature controller and a heating
adapter plate, CA, USA) and using a 1006 UplanSApo oil
immersion/1.4 NA (numerical aperture) objective (Olympus, Japan).
Images were taken using 3 x digital zoom, and an appropriated pinhole
to obtain 1 Airy unit for the fluorochrome of shortest wavelength
excitation/emission properties (optical slice 0.8 mm). Images of
different cells for each dish were taken in a period no longer than
30 min. Images are representative of at least three independent
experiments.
ii) Live Cell Imaging for Deacylation Kinetic Measure-
ments. For deacylation measurements, cells coexpressing
N13GAP-43(C3S)-YFP and
N27GalNAcT-CFP, a TGN marker,
or
N13GAP-43(C3S)-YFP,
N27GalNAcT-CFP and Cherry-APT-1
or Cherry-APT-2, were used. Live cell experiments were
performed at 20uC on the Olympus FluoView FV1000 confocal
microscope to minimize vesicular trafficking of GAP-43 [34,62].
After selection of cells coexpressing all proteins (e.g.,
N27GalNAc-
T-CFP,
N13GAP-43(C3S) and cherry-APT-1 or cherry-APT-2),
images were acquired in the CFP and YFP channels for
deacilation kinetic measurements. A 40 x/1.3 NA PlanApo
objective oil immersion (Olympus) was used with a 5 x digital
zoom. The image resolution was 320x320 pixels, the scan speed
was 10 ms/pixel and the pinhole adjusted to obtain an optical slice
of 3 mm. Single 2D images were taken at a frequency of 1 min
-1,
for 30 minutes. These acquisition conditions were optimized to
acquire the Golgi compartment, to minimize bleaching during
acquisition and to sample as fast as possible the amount of
N13GAP-43(C3S) at the TGN.
Quantitative mage Analysis for Deacylation Experiments
All image analysis and quantification procedures were done
using ImageJ software. Significant fluorescent pixels were isolated
from raw images of each channel (CFP and YFP channels) by
applying the following equation:
Im ½ 
Ch,i
BS ~ Im ½ 
Ch,i
R {3:b
Ch,i
sd 1 ½ 
Where Im ½ 
Ch,i
R is the matrix (image) containing the gray values
of the raw image of channel i, b
Ch,i
sd is a scalar representing the
standard deviation of intensity of background pixels and [1]i sa
unitary matrix of equal size of Im ½ 
Ch,i
R .b sd was obtained from a
50650 pixel region from an area empty of cells. Negative elements
resulting from the above equation are defined as 0 and
consequently the elements of the Im ½ 
Ch,i
BS matrix are greater or
equal to 0. The threshold 3:b
Ch,i
sd allows discriminate those pixels
whose intensity is significantly different from the background
noise. Although the intensity distribution of pixels is not normal,
we did not obtain differences by applying the above equation or a
threshold containing the 90% of background pixels (data not
shown).
A mask M ½ 
Ch,i, containing the position of significant pixels in
Im ½ 
Ch,i
BS was generated by applying a threshold value equal to 1,
and then substrating a value of 254 in Image J. The resulting
image was then converted to 16 bit for compatibility purposes.
The M ½ 
Ch,i matrix has values 0 and 1. Then, objects with a
diameter smaller than 8 pixels were discarded with the remove
objects plugin of Image J. Once obtained M ½ 
Ch,i, pixelsij in the raw
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Im ½ 
Ch,i
SP

ij
~ Im ½ 
Ch,i
R

ij
: M ½ 
Ch,i

ij
i.e, by multiplying raw and mask images using the image calculator
tool.
For TGN masks (i.e. those derived from
N27GalNAcT-CFP
images) the background level in the CFP channel was determined
around the organelle and not from an area empty of cells since in
our conditions a fraction of
N27GalNAc-T-CFP was present in the
endoplasmic reticulum. After creating each TGN mask, we
measured the area of TGN in pixel number units as:
AreaTGN~sum M ½ 
TGN

ROI
Where TGN refers to the CFP channel. The sum of the elements
of the mask was performed over a ROI that completely involves
the organelle in all the time series of a single cell.
By multiplying each ij pixel of the Im ½ 
YFP
SP (the 2-D matrix
containing the significant
N13GAP-43(C3S)-YFP data) by the
corresponding of M ½ 
TGN, we obtain
Im ½ 
YFP
TGN

ij
~ Im ½ 
YFP
SP

ij
: M ½ 
TGN

ij
and the integrated YFP fluorescence intensity inside the organelle
is obtained by
FluorescenceTGN
YFP ~sum Im ½ 
YFP
TGN

ROI
Where the ROI is the same that was employed to determine TGN
area. The
N13GAP-43(C3S)-YFP concentration is determined by
dividing FluorescenceTGN
YFP by AreaTGN.
N13GAP{43 C3S ðÞ {YFP
 TGN
~
FluorescenceTGN
YFP
AreaTGN
Because we were interested how GAP-43 is distributed between
TGN and cytoplasm and the above parameters scaling up with
protein expression, we measured the TGN to cytoplasm
concentration ratio at each time i as follow:
Kp N13GAP{43 C3S ðÞ {YFP
 TGN i ðÞ 
~
N13GAP{43 C3S ðÞ {YFP
 TGN i ðÞ
N13GAP{43 C3S ðÞ {YFP ½ 
Cyt i ðÞ
Where TGN and Cyt refers to the TGN and cytoplasm,
respectively. The concentration of GAP-43 at the cytoplasm was
determined by measuring the average gray value (integrated gray
value/number of pixels of the ROI) of GAP-43 in a small region of
interest located in the cytoplasm. Typically, the cytoplasmic ROI
area was comparable to that of TGN marker area. Thus, data
acquisitions are independent of organelle size and initial steady
state conditions. Moreover, these parameters were also indepen-
dent of GAP-43 expression levels and TGN size, as previously
described [34].
For GAP-43 deacylation, we considered that after an infinite
period of acylation inhibition in the presence of an active
deacylation mechanism, the amount of TGN associated GAP-43
completely vanish. At this point, GAP-43 is completely dissociated
from TGN and only localizes at the cytosol as a soluble protein.
For this reason, we expect that the Kp parameter reach 1 at this
time. In this sense, it was considered more appropriate to describe
the acylation state measured as the amount of TGN-membrane
associated GAP-43 as follow:
TGN{membrane:associatedGAP{43~
Kp N13GAP{43 C3S ðÞ {YFP
 TGN i ðÞ 
Kp N13GAP{43 C3S ðÞ {YFP ½ 
TGN 0 ðÞ
 {1
Where Kp N13GAP{43 C3S ðÞ {YFP
 TGN i ðÞ 
and Kp
N13GAP{43 C3S ðÞ {YFP
 TGN 0 ðÞ 
are the TGN to cytoplasm
concentration ratios of
N13GAP-43(C3S) at time i and 0,
respectively.
mRNA Purification and RT-PCR
Animal handling was performed according to the standards
stated in the Guide to the Care and Use of Experimental Animals
published by the Canadian Council on Animal Care and approved
by the local Institution (Facultad de Ciencias Quı ´micas, Uni-
versidad Nacional de Co ´rdoba, Argentina, Exp. Nu 15-99-40426).
For hamster tissue mRNA purification and analyses, hamsters
were anesthetized and different organs extracted. Then, the tissues
were homogenized with an Ultraturrax tissue disintegrator and
lysates were passed through a Dounce homogenizer until
homogeneity. Then, the cleared lysates were centrifuged at
13000 g and mRNA or genomic DNA were extracted using
mRNA and genomic DNA extraction kits from GE healthcare and
Sigma-Aldrich, respectively.
For tissue cultured cells, 24 h after seeding or differentiation,
cells were washed with cold phosphate buffered saline (PBS) and
harvested by scrapping in PBS. Extracts were centrifugated at
13000 g for 15 min and mRNA or genomic DNA purified using
the commercial extraction kits, according to manufacture
instructions. After purification, reverse transcriptase-PCR was
performed using 2 mg of purified mRNA as template. Alternative-
ly, PCR was performed using 50 ng of genomic DNA. Primers are
described in supplemental Table S1.
Bioinformatic Search for Acyl-Protein Thiosterases
First, we performed a Blast search for nonredundant human
protein sequences (nonredundant human database) which align to
PPT-1 (NP_000301.1) and/or APT-1 (NP_006321.1) protein
sequences [63,64]. In addition, we attempted to identify members
of PPT-1 and/or APT-1 families in Pfam databases (http://pfam.
sanger.ac.uk/) [#PF02230 (APT-1) and #PF02089 (PPT-1)] [65].
Overall, we obtained four groups of proteins. After discarding
redundant sequences, the resulting proteins were grouped
according to their coding genes. Finally, we obtained five different
genes coding for 21 mRNA transcripts which are potentially
involved in the expression of acyl-protein thioesterase enzymes
(Table S1).
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Figure S1 In vivo deacylation of single acylated GAP-
43
full(C3S). A) CHO-K1 cells transiently expressing GAP-
43
full(C3S)-YFP [GAP-43
full(C3S)] were treated with 50 mM2 -
BP (2-BP) or vehicle (Control) for 2 h. Then, cells were lysed,
ultracentrifuged and the S (soluble) and P (pellet) fractions isolated.
Buffer containing 1% v/v TX-114 was added to samples and the
phase separation was induced at 37uC. Proteins from the A
(aqueous) and D (detergent) phases were Western blotted with an
antibody to GFP. The lowest panels show the Western blot using
antibody to a-tubulin. B) Quantification of Western blot showed
in A (see Materials and Methods). Kp=K1/K2, where K1=P
GAP-43/S GAP-43 and K2=P tubulin/S tubulin. Kp con-
trol=100%.
(TIF)
Figure S2 APT-1 expression analysis in COS-7 and
CHO-K1 cells. PCR analysis of APT-1 expression using the
following templates: first-strand cDNA obtained from RT of
CHO-K1 cells purified mRNA (RT-PCR CHO-K1); the reaction
mixture [Ctrl (-)]; total mRNA from CHO-K1 cells (Total RNA
CHO-K1); first-strand cDNA obtained from RT of COS-7 cells
purified mRNA (RT-PCR COS-7); genomic DNA from CHO-K1
cells (gDNA CHO-K1) and from COS-7 cells (gDNA COS-7).
Genomic DNA and mRNA were extracted from CHO-K1 and
COS-7 cells 2 day after seeding in 100 mm Petri dishes.
(TIF)
Figure S3 APT-1 overexpression did not significantly
modify membrane association and deacylation kinetic
of diacylated
N13GAP-43 and GAP-43
full. 60 h after transient
transfection, CHO-K1 cells coexpressing GAP-43
full and APT-1
(A)o r
N13GAP-43 and APT-1 (B) were treated with 50 mM 2-BP
(2-BP) or vehicle (Ctrl) in the presence of CHX and protein
degradation inhibitors for 0, 3 and 6 h and the GAP-43 subcellular
distribution was analyzed by live cell confocal microscopy. Each
panel shows image from YFP fluorescence (pseudocolored gray).
The insets show the cells expressing APT-1 (cherry fluorescence,
pseudocolored gray). Scale bar: 5 mm.
(TIF)
Figure S4 Analysis of acyl-protein thioesterase expres-
sion in SH-SY5Y and SK-Mel 28 cells. A) PCR screening of
acyl-protein thioesterase gene expression in SH-SY5Y, treated
(RA) or not (Ctrl) with retinoic acid (middle and upper panels,
respectively), and SK-Mel 28 human cells (lower panels). For each
indicated gene (see gene accession number at the bottom), PCRs
were performed using specific primers and the following templates:
reaction mixture [Ctrl (-)]; SH-SY5Y or SK-Mel 28 genomic DNA
(gDNA) and first-strand cDNA obtained from RT of SH-SY5Y or
SK-Mel 28 cells purified mRNA (RT-PCR). B) PCR analysis of
isoform expression coded by gene # 11313. For each isoform
indicated at the right (with the corresponding accession number),
PCRs were performed using specific primers and the following
templates: first-strand cDNA obtained from RT of SH-SY5Y
[treated (RA) or not (Ctrl) with retinoic acid] or SK-Mel 28 cells
purified mRNA (RT-PCR); SH-SY5Y or SK-Mel 28 genomic
DNA (gDNA).
(TIF)
Table S1 Bioinformatic data of genes potentially coding
acyl-protein thioesterases and PCR primer sequences.
(DOC)
Table S2 Aminoacid and nucleotide sequence align-
ments of APT-2 from CHO-K1 and Hela cells.
(DOC)
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